CPT code 11983 covers the removal of a non‑biodegradable implant (capsule or pellet) that provides controlled‑release drug delivery, followed by insertion of a new implant. This combined explantation and replacement procedure is relevant across specialties that manage long‑acting drug delivery implants, including pain management, endocrinology, and certain surgical practices. Nationally, the code matters because it captures care for ongoing chronic therapies delivered via implants and affects billing where device longevity, local anesthesia, and minor surgical resources intersect.

Key payers in the scope of this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for CPT code 11983, the typical settings where the service is delivered, and what to expect in payer coverage discussions. The publication outlines benchmarks and reimbursement context, summarizes common modifier usage and related coding considerations where available, and highlights policy updates that influence payment and documentation expectations. It also provides clinical context for when combined removal and replacement procedures are coded versus separate services.

Data not available in the input for specific covered diagnoses, taxonomies, or payer-specific reimbursement rates is noted where applicable.